India: +91-40-42023318 | Singapore: +65-31631880
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Clinical Trial News

Peanut allergy could be cured with probiotics

The vast majority of children in a large clinical trial continued to tolerate peanuts for 4 years after it had ended, new research shows.

Reversing brain death: Far-fetched or feasible?

Ira Pastor, CEO of Bioquark, Inc., speaks to MNT about his team's controversial plans to restore life to people who have been declared brain dead.

'Accelerated approval' drugs: How well are they studied?

When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and Drug Administration (FDA) has special programs available to...

Prostate cancer: Study identifies earlier clinical trial endpoint that can be used to indicate effectiveness of new treatments

Scientists say they have validated a "surrogate endpoint" - a reliable statistical shortcut in a clinical trial - that could accelerate testing of new adjuvant therapies aimed at reducing deaths from...

Immunotherapy found safe for type 1 diabetes in landmark trial

A new trial investigates the safety profile of proinsulin peptide immunotherapy for treating type 1 diabetes, and the results are encouraging.

Could vitamin B-3 help to prevent melanoma?

A new review suggests that nicotinamide - a form of vitamin B-3 - could be a promising candidate for the prevention of melanoma, the deadliest skin cancer.

Diabetes shot boosts motor function for patients with Parkinson's

A placebo trial shows that the diabetes drug exenatide improved motor symptoms of Parkinson's disease and may have disease-altering potential.

New compound boosts treatment for aggressive breast cancer

A new anticancer agent, if given in combination with existing treatment, proves highly effective against triple negative and HER2 positive breast cancers.



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook